日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis

造血干细胞移植后复发性急性白血病或骨髓增生异常综合征的供者淋巴细胞输注:单中心回顾性分析

Ogasawara, Masahiro; Nozu, Rintaro; Miki, Kosuke; Sugimura, Shunnsuke; Kojima, Keisuke; Hidaka, Daisuke; Ogasawara, Reiki; Okada, Kohei; Sugita, Junichi; Kobayashi, Naoki; Imamura, Masahiro; Ota, Shuichi

Long-term follow-up of efficacy and safety in elderly patients with chronic myeloid leukemia treated with intermittent low dose dasatinib therapy

对接受间歇性低剂量达沙替尼治疗的慢性粒细胞白血病老年患者进行长期疗效和安全性随访

Imamura, Masahiro; Nakamura, Yusuke; Hidaka, Daisuke; Ogasawara, Reiki; Okada, Kohei; Sugita, Junichi; Ota, Shuichi

The preceding hyponatremia is a useful hallmark for the diagnosis of HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation

异基因造血干细胞移植后,低钠血症是诊断HHV-6脑炎的一个重要特征。

Yoshida, Shota; Ara, Takahide; Okada, Kohei; Mori, Yuto; Tsukamoto, Shihori; Miyashita, Naoki; Kasahara, Kohei; Ebata, Ko; Iwasaki, Junko; Takahashi, Shojiro; Shigematsu, Akio; Minauchi, Koichiro; Kobayashi, Naoki; Ogasawara, Masahiro; Imamura, Masahiro; Teshima, Takanori; Ota, Shuichi

Role of loss and skew of X chromosome inactivation for developing myelodysplastic syndrome in patients with Klinefelter syndrome: A brief review of the literature

X染色体失活缺失和偏倚在克氏综合征患者发生骨髓增生异常综合征中的作用:文献简述

Imamura, Masahiro

New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination

接种BNT162b2 mRNA COVID-19疫苗后出现新发埃文斯综合征合并系统性红斑狼疮

Hidaka, Daisuke; Ogasawara, Reiki; Sugimura, Shunsuke; Fujii, Fumiaki; Kojima, Keisuke; Nagai, Jun; Ebata, Ko; Okada, Kohei; Kobayashi, Naoki; Ogasawara, Masahiro; Imamura, Masahiro; Ota, Shuichi

Perspectives on the Use of a Medium-Dose Etoposide, Cyclophosphamide, and Total Body Irradiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation: The Japanese Experience from 1993 to Present

异基因造血干细胞移植中应用中等剂量依托泊苷、环磷酰胺和全身照射预处理方案的展望:日本1993年至今的经验

Imamura, Masahiro; Shigematsu, Akio

Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host Disease.

可溶性 DNAM-1 作为急性移植物抗宿主病的预测生物标志物

Kanaya Minoru, Shibuya Kazuko, Hirochika Rei, Kanemoto Miyoko, Ohashi Kazuteru, Okada Masafumi, Wagatsuma Yukiko, Cho Yukiko, Kojima Hiroshi, Teshima Takanori, Imamura Masahiro, Sakamaki Hisashi, Shibuya Akira

Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioning

异基因造血干细胞移植治疗成人急性淋巴细胞白血病:中剂量依托泊苷预处理的潜在益处

Imamura, Masahiro; Shigematsu, Akio

A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia

一项关于中等剂量依托泊苷、环磷酰胺和全身照射预处理方案在异基因造血干细胞移植治疗急性淋巴细胞白血病中的安全性和有效性研究

Shigematsu, Akio; Ozawa, Yukiyasu; Onizuka, Makoto; Fujisawa, Shin; Suzuki, Ritsuro; Atsuta, Yoshiko; Hatanaka, Kazuo; Masuko, Masayoshi; Ito, Toshiro; Kobayashi, Naoki; Kato, Jun; Miyamura, Koichi; Fukuda, Takahiro; Morishima, Yasuo; Imamura, Masahiro

HCV virus and lymphoid neoplasms

丙型肝炎病毒与淋巴瘤

Tsutsumi, Yutaka; Ito, Shinichi; Ogasawara, Reiki; Kudo, Kazuhiro; Tanaka, Junji; Asaka, Masahiro; Imamura, Masahiro